| It Ain't Over 'Til the Fat Lady Sings. | |
| | |
MedLine Citation:
|
PMID: 22914620 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
The antiatherogenic drug nicotinic acid (niacin) has antidyslipidemic effects independent of free fatty acid suppression mediated by its receptor HCA(2) (GPR109A) (Lauring et al., this issue). |
| | |
Authors:
|
Stefan Offermanns |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Science translational medicine Volume: 4 ISSN: 1946-6242 ISO Abbreviation: Sci Transl Med Publication Date: 2012 Aug |
Date Detail:
|
Created Date: 2012-08-23 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101505086 Medline TA: Sci Transl Med Country: United States |
Other Details:
|
Languages: eng Pagination: 148fs30 Citation Subset: IM |
Affiliation:
|
Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Ludwigstr. 43, 61231 Bad Nauheim, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Anxiety disorders in old age.
Next Document: Niacin Lipid Efficacy Is Independent of Both the Niacin Receptor GPR109A and Free Fatty Acid Suppres...